Previous 10 | Next 10 |
PRINCETON, N.J., May 11, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat as part of the 2020 RBC Capital Markets Global ...
SAExploration Holdings (NASDAQ: SAEX ) -25% . More news on: SAExploration Holdings, Inc., My Size, Inc., Pinterest, Inc., Stocks on the move, , Read more ...
Agile Therapeutics (NASDAQ: AGRX ): Q1 GAAP EPS of -$0.10 misses by $0.01 . More news on: Agile Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
FDA Approved Twirla ® Expected to Reach Wholesalers in the Fourth Quarter of 2020 $93.9 Million in Cash and Cash Equivalents as of March 31, 2020 Management to Host Conference Call at 4:30 PM ET PRINCETON, N.J., May 05, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (...
Agile Therapeutics (NASDAQ: AGRX) , a small-cap women's healthcare company, is starting the week off on the right foot. Specifically, the drugmaker's shares are up by 11.2% on extremely heavy volume, as of 10:40 a.m. EDT Monday. Unfortunately, the spark behind this double-digit m...
Stemline Therapeutics (NASDAQ: STML ) +151% on Menarini bid . More news on: Stemline Therapeutics, Inc., Applied DNA Sciences, Inc., KLX Energy Services Holdings, Inc., Stocks on the move, , Read more ...
3 Penny Stocks That Hit It Big You may be wondering if penny stocks are worth it or not. There’s so much misinformation floating around about these cheap stocks that it can make your head spin. But we’re here to clear the air and let you know that people can make money with pen...
Introduction Agile Therapeutics (NASDAQ: AGRX ) is a women’s healthcare company focused on patch-based contraceptive options. Their lead product, Twirla, is a once-a-week contraceptive patch containing a combined dose of levonorgestrel and ethinyl estradiol. Twirla was recently appr...
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., April 23, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced it will report first quarter 2020 financial results after the market close...
PRINCETON, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon Barbari for election as a class III director to replace Abhijeet Lele, a member of the com...
News, Short Squeeze, Breakout and More Instantly...
Agile Therapeutics Inc. Company Name:
AGRX Stock Symbol:
OTCMKTS Market:
Agile Therapeutics Inc. Website:
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...